PATENT CLAIM ANALYSIS

Application Number: 15766736
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "265100"]

Abstract:
Provided are methods of making certain pyrrolopyrimidine derivatives, which are useful in the treatment of proliferation disorders and other diseases related to the dysregulation of kinase (such as, but not limited to, EGFR (including HER), Alk, PDGFR, BLK, BMX/ETK, BTK, FLT3 (D835Y), ITK, JAK1, JAK2, JAK3, TEC and TXK) and/or the respective pathways, salts, polymorphs, and amorphous forms of said compounds, synthetic intermediates for preparing said compounds, and pharmaceutical compositions comprising said compounds and methods for making such compositions.

Claim (Index 35):
The pharmaceutical composition of  claim 1 , which comprises at least two different kinds of adsorbing agents, and further comprises a disintegrating agent and a lubricant.

Metadata:
- Claim Count in Document: 166.0
- Percentile: 91.0
- Lexical Diversity: 1.66667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14420341', '15708024', '14712794', '15509569', '13843554']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7186565750375319
- 35 USC 102 Novelty (BERT): 0.5387576145866826
- Combined Prediction Score: 0.700666678992447
- Mean Citation Score: 339.1113220000001
- Max Citation Score: 346.8182700000001
- Similarity Product: 217.4092785964609

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test